Background/Purpose: The VPAC1 receptor, a member of the vasoactive intestinal peptide receptors (VIPRs), is overexpressed in the most frequently occurring malignant tumors and plays a major role in the progression and angiogenesis of a number of malignancies. Recently, phage display has become widely used for many applications, including ligand generation for targeted imaging, drug delivery and therapy. In this work, we developed a panning procedure using a phage display peptide library to select a peptide that specifically binds to the VPAC1 receptor to develop a novel targeted probe for molecular imaging and therapy. Methods: CHO-K1 cells stably expressing VPAC1 receptors (CHO-K1/VPAC1 cells) were used to select a VPAC1-binding peptide fr...
OBJECTIVES: We carried out identification of a small peptide binding to human hepatocellular carcin...
Multi-membrane spanning proteins, such as G protein-coupled receptors (GPCRs) and ion channels, are ...
OBJECTIVES We carried out identification of a small peptide binding to human hepatocellular carci...
BACKGROUND/PURPOSE: The VPAC1 receptor, a member of the vasoactive intestinal peptide receptors (VIP...
The VPAC1 receptor, a member of the vasoactive intestinal peptide receptors (VIPRs), is overexpresse...
The VPAC1 receptor, a member of the vasoactive intestinal peptide receptors (VIPRs), is overexpresse...
<div><h3>Background/Purpose</h3><p>The VPAC1 receptor, a member of the vasoactive intestinal peptide...
Tumor-targeting therapy can be an efficacious way to cure a malignant tumor in clinical trials. Phag...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
Background and Aim: Prostate cancer is one the most common causes of cancer-associated death in men....
Phage display is a method to discover peptide ligands while minimizing and optimizing the structure ...
Multi-membrane spanning proteins, such as G protein-coupled receptors (GPCRs) and ion channels, are ...
OBJECTIVES: We carried out identification of a small peptide binding to human hepatocellular carcin...
OBJECTIVES: We carried out identification of a small peptide binding to human hepatocellular carcin...
Multi-membrane spanning proteins, such as G protein-coupled receptors (GPCRs) and ion channels, are ...
OBJECTIVES We carried out identification of a small peptide binding to human hepatocellular carci...
BACKGROUND/PURPOSE: The VPAC1 receptor, a member of the vasoactive intestinal peptide receptors (VIP...
The VPAC1 receptor, a member of the vasoactive intestinal peptide receptors (VIPRs), is overexpresse...
The VPAC1 receptor, a member of the vasoactive intestinal peptide receptors (VIPRs), is overexpresse...
<div><h3>Background/Purpose</h3><p>The VPAC1 receptor, a member of the vasoactive intestinal peptide...
Tumor-targeting therapy can be an efficacious way to cure a malignant tumor in clinical trials. Phag...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
Colorectal cancer is frequently diagnosed at an advanced stage due to the absence of early clinical ...
Background and Aim: Prostate cancer is one the most common causes of cancer-associated death in men....
Phage display is a method to discover peptide ligands while minimizing and optimizing the structure ...
Multi-membrane spanning proteins, such as G protein-coupled receptors (GPCRs) and ion channels, are ...
OBJECTIVES: We carried out identification of a small peptide binding to human hepatocellular carcin...
OBJECTIVES: We carried out identification of a small peptide binding to human hepatocellular carcin...
Multi-membrane spanning proteins, such as G protein-coupled receptors (GPCRs) and ion channels, are ...
OBJECTIVES We carried out identification of a small peptide binding to human hepatocellular carci...